Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3/24/25 21:00 | 3/21/25 | ATAI | Health | Drug | Pharmaceutical Preparations | Kirpekar Sahil | 2M | O | Chief Bu | 2 | S.d | -66 | 0.4413 | 0 | -149 | 164 | D | |||||||||||||||
3/24/25 21:00 | 3/21/25 | ATAI | Health | Drug | Pharmaceutical Preparations | Craig Kevin James | 2M | O | Chief Me | 2 | S.d | -16 | 0.4946 | 0 | -32 | 20 | D | |||||||||||||||
3/24/25 21:00 | 3/21/25 | ATAI | Health | Drug | Pharmaceutical Preparations | Rao Srinivas | 2M | O | See Rema | 2 | S.d | -102 | 0.4066 | 0 | -250 | 292 | D | |||||||||||||||
3/24/25 21:00 | 3/21/25 | ATAI | Health | Drug | Pharmaceutical Preparations | Johnson Anne Nagengast | 2M | O | CFO | 2 | S.d | -45 | 0.3391 | 0 | -134 | 174 | D | |||||||||||||||
3/24/25 21:00 | 3/21/25 | ATAI | Health | Drug | Pharmaceutical Preparations | Short Glenn Frank | 2M | O | Chief Sc | 2 | S.d | -18 | 0.3891 | 0 | -46 | 55 | D | |||||||||||||||
3/24/25 17:00 | 3/24/25 | ATAI | Health | Drug | Pharmaceutical Preparations | Apeiron Investment Group Ltd. | O1 | T | 2 | P | 25,275 | 2.00 | 0 | 12,636 | 40 | 44,169 | I |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |